Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Mollevi DG"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Latacz E; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium., Höppener D; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Bohlok A; Department of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium., Leduc S; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Tabariès S; Department of Medicine, Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada., Fernández Moro C; Department of Laboratory Medicine, Division of Pathology, Karolinska Institutet, Huddinge, Sweden.; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge, Sweden., Lugassy C; Department of Translational Research, Institut Curie, Paris, France., Nyström H; Department of Surgical and Perioperative Sciences, Surgery, Umeå University, Umeå, Sweden.; Wallenberg Centre for Molecular Medicine, Umeå University, Umeå, Sweden., Bozóky B; Department of Clinical Pathology and Cancer Diagnostics, Karolinska University Hospital, Huddinge, Sweden., Floris G; Department of Imaging and Pathology, Laboratory of Translational Cell & Tissue Research and University Hospitals Leuven, KU Leuven, Leuven, Belgium.; Department of Pathology, University Hospitals Leuven, Campus Gasthuisberg, Leuven, Belgium., Geyer N; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden., Brodt P; Department of Surgery, Oncology and Medicine, McGill University and the Research Institute, McGill University Health Center, Montreal, QC, Canada., Llado L; HBP and Liver Transplantation Unit, Department of Surgery, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain., Van Mileghem L; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium., De Schepper M; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Majeed AW; Sheffield Teaching Hospitals NHS Trust, Sheffield, UK., Lazaris A; Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada., Dirix P; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium., Zhang Q; School of Electronic Engineering and Computer Science, Queen Mary University of London, London, UK., Petrillo SK; Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada., Vankerckhove S; Department of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium., Joye I; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium., Meyer Y; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Gregorieff A; Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada.; Department of Pathology, McGill University, Montreal, QC, Canada.; Regenerative Medicine Network, McGill University, Montreal, QC, Canada., Roig NR; Department of Pathology, Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Tumoral and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Human Anatomy and Embryology Unit, Department of Pathology and Experimental Therapeutics, Faculty of Medicine and Health Sciences, Universitat de Barcelona, Barcelona, Catalonia, Spain., Vidal-Vanaclocha F; GWU-Cancer Center, Department of Biochemistry and Molecular Medicine, School of Medicine & Health Sciences, The George Washington University, Washington, DC, USA., Denis L; Department of Pathology, Institut Jules Bordet, Brussels, Belgium., Oliveira RC; Pathology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal.; Clinical Academic Center of Coimbra (CACC), Coimbra, Portugal.; Coimbra Institute for Clinical and Biomedical Research (iCBR) area of Environment Genetics and Oncobiology (CIMAGO), Institute of Biophysics, Faculty of Medicine, University of Coimbra, Coimbra, Portugal., Metrakos P; Cancer Research Program, McGill University Health Centre Research Institute, Montreal, QC, Canada., Grünhagen DJ; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Nagtegaal ID; Department of Pathology, Radboud University Medical Center, Nijmegen, Netherlands., Mollevi DG; Tumoral and Stromal Chemoresistance Group, Oncobell Program, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain.; Program Against Cancer Therapeutic Resistance (ProCURE), Institut Català d'Oncologia, L'Hospitalet de Llobregat, Barcelona, Catalonia, Spain., Jarnagin WR; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., D'Angelica MI; Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Reynolds AR; Oncology R&D, AstraZeneca, Cambridge, UK., Doukas M; Department of Pathology, Erasmus Medical Center, Rotterdam, The Netherlands., Desmedt C; Laboratory for Translational Breast Cancer Research, Department of Oncology, KU Leuven, Leuven, Belgium., Dirix L; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium., Donckier V; Department of Surgical Oncology, Institut Jules Bordet, Brussels, Belgium., Siegel PM; Department of Medicine, Rosalind and Morris Goodman Cancer Research Institute, McGill University, Montreal, QC, Canada.; Departments of Medicine, Biochemistry, Anatomy & Cell Biology, McGill University, Montreal, QC, Canada., Barnhill R; Department of Translational Research, Institut Curie, Paris, France.; Université de Paris l'UFR de Médecine, Paris, France., Gerling M; Department of Biosciences and Nutrition, Karolinska Institutet, Huddinge, Sweden.; Theme Cancer, Karolinska University Hospital, Solna, Sweden., Verhoef C; Department of Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Vermeulen PB; Translational Cancer Research Unit, GZA Hospitals, Iridium Netwerk and University of Antwerp, Antwerp, Belgium. peter.vermeulen@gza.be.
Publikováno v:
British journal of cancer [Br J Cancer] 2022 Oct; Vol. 127 (6), pp. 988-1013. Date of Electronic Publication: 2022 Jun 01.
Autor:
Latacz E; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Iridium Kankernetwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium., van Dam PJ; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium; Histogenex, Antwerp, NV, Belgium., Vanhove C; Institute Biomedical Technology, Department Electronics and Information, Ghent University, Ghent, Belgium., Llado L; Tumor and Stromal Chemoresistance, Molecular Mechanisms and Experimental Therapeutics in Oncology program ONCOBELL, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; HBP and Liver Transplantation Unit, Department of Surgery, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Descamps B; Institute Biomedical Technology, Department Electronics and Information, Ghent University, Ghent, Belgium., Ruiz N; Tumor and Stromal Chemoresistance, Molecular Mechanisms and Experimental Therapeutics in Oncology program ONCOBELL, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Joye I; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Iridium Kankernetwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium., Grünhagen D; Department of Surgical Oncology and Gastrointestinal Surgery, Erasmus MC Cancer Institute, Rotterdam, The Netherlands., Van Laere S; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Iridium Kankernetwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium., Dirix P; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Iridium Kankernetwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium., Mollevi DG; Tumor and Stromal Chemoresistance, Molecular Mechanisms and Experimental Therapeutics in Oncology program ONCOBELL, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain; Program Against Cancer Therapeutic Resistance ProCure, Catalan Institute of Oncology, L'Hospitalet de Llobregat, Barcelona, Spain., Verhoef C; Department of Pathology, Hospital Universitari de Bellvitge, IDIBELL, L'Hospitalet de Llobregat, Barcelona, Spain., Dirix L; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Department of Oncological Research, GZA Hospital Sint-Augustinus, Antwerp, Belgium., Vermeulen P; Translational Cancer Research Unit, GZA Hospitals, Sint-Augustinus, Antwerp, Belgium; Iridium Kankernetwerk, Antwerp, Belgium; Center for Oncological Research (CORE), Faculty of Medicine and Health Sciences, University of Antwerp, Wilrijk, Antwerp, Belgium. Electronic address: peter.vermeulen@gza.be.
Publikováno v:
Seminars in cancer biology [Semin Cancer Biol] 2021 Jun; Vol. 71, pp. 33-41. Date of Electronic Publication: 2020 Jul 28.